Posted by Michael Wonder on 10 May 2022
High-risk COVID-19 patients can now get two antiviral prescription drugs — but some are still missing out
10 May 2022 - For Australians at high risk of developing severe COVID-19, getting access to potentially lifesaving treatment recently became easier — but experts say some are still missing out.
On May 1, COVID-19 anti-viral drug Paxlovid — the most effective oral treatment to date — was listed on the Pharmaceutical Benefits Scheme, which means it can now be prescribed by a GP or nurse and dispensed at a community pharmacy.
